The startup develops a proprietary wire-based medical device and generator console that delivers shockwave energy to treat chronic total occlusions in patients with peripheral artery disease and coronary artery disease. This technology enables healthcare professionals to effectively restore blood flow in obstructed arteries, improving patient outcomes.
Funding
$48.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic total occlusions (CTOs) and heavily calcified lesions in peripheral and coronary arteries pose significant challenges during interventional procedures. These blockages are difficult to cross with standard guidewires, often leading to prolonged procedure times and increased risk of complications such as perforation or dissection. Current methods may not be effective in modifying the calcium, hindering successful revascularization.
Solution
Soundbite Medical offers an intravascular lithotripsy (IVL) system designed to safely and effectively treat calcified lesions and CTOs. The system utilizes a proprietary method to generate and deliver shockwaves via a wire-based device, facilitating the intraluminal placement of guidewires and treatment devices beyond the occlusion. This technology enables healthcare professionals to modify calcified plaque, restore blood flow, and improve outcomes in patients with peripheral artery disease (PAD) and coronary artery disease (CAD). The SoundBite system aims to simplify complex interventions, reduce the risk of complications, and improve the overall efficiency of revascularization procedures.
Target Audience
The primary target audience includes interventional cardiologists, vascular surgeons, and interventional radiologists who treat patients with peripheral artery disease and coronary artery disease, specifically those with chronic total occlusions and heavily calcified lesions.
Features
- SoundBite XS Crossing System: IVL wire-based technology designed to cross chronic total occlusions in peripheral arteries.
- Active Wire Technology: Facilitates intraluminal wire passage through the proximal cap and the CTO lesion.
- Waveguide Technology: Array of waveguides to deliver shock waves to calcific lesions across different vascular beds.
- Efficient on Calcium: Designed to effectively modify calcium within the artery.
- Compatible with standard platforms: Designed for efficient integration into existing workflows with a minimal learning curve.
- Active Microcatheter (In Development): Designed to modify intraluminal calcific plaque and compatible with the XS System Console.